The New England Journal of Medicine | Research & Review …
The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of ...
New England Journal of Medicine
The New England Journal of Medicine is a leading medical journal providing research, reviews, and commentary on clinical practice and biomedical science.
Current Issue | New England Journal of Medicine
Explore the current issue of The New England Journal of Medicine (Vol. 391 No. 24).
Nonsurgical Management of Chronic Venous Insufficiency
2024年12月18日 · Chronic venous insufficiency arises from a complex interplay of genetic predisposition; environmental factors, such as jobs that require prolonged standing or carrying heavy loads; and age-related ...
Recently Published - The New England Journal of Medicine
2024年12月11日 · The BALANCE Investigators, for the Canadian Critical Care Trials Group, the Association of Medical Microbiology and Infectious Disease Canada Clinical Research Network, the Australian and New ...
Depemokimab in Severe Asthma | New England Journal of Medicine
2024年12月18日 · Depemokimab, an ultra-long-acting biologic agent with enhanced binding affinity for interleukin-5, may improve outcomes in patients with asthma with an eosinophilic phenotype.
Durvalumab in Small-Cell Lung Cancer | NEJM
2024年12月18日 · To the Editor: Results of the phase 3 ADRIATIC trial (Oct. 10 issue)1 marked a breakthrough in the treatment of limited-stage small-cell lung cancer, but some questions remain unanswered.
Ponsegromab for Cancer Cachexia — A New Dawn for an Old …
2024年12月18日 · Hippocrates, the father of medicine (460 to 370 b. c.), described cachexia as a condition in which “the flesh is consumed and becomes water,…the abdomen fills with water, the feet and legs ...
Nephrology - The New England Journal of Medicine
2024年12月14日 · A 38-year-old man with a history of kidney transplantation presented with a 2-week history of burning, hairy lesions on his tongue. Examination revealed elongated, discolored papillae on the tongue.
Original Article - The New England Journal of Medicine
6 天之前 · In two replicate trials, depemokimab, an ultra-long-acting anti–interleukin-5 biologic therapy, reduced exacerbations in patients who had severe asthma with an eosinophilic phenotype.